Clinical Trials | April 26, 2022
SRL Diagnostics opens state-of-the-art laboratory in Jamshedpur
The new lab in the industrial town is SRL’s 4th lab in the state of Jharkhand
The new lab in the industrial town is SRL’s 4th lab in the state of Jharkhand
This is the first major brand refresh of CanSinoBIO since its inception in 2009
Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab
Access Healthcare for Medical Products (Access Healthcare) provides pharmaceutical companies with innovative marketing and sales solutions in the MENA (Middle East & North Africa) region
Healthium Medtech, a company focused on products used in surgical, post-surgical and chronic care has ramped up its play in the global healthcare industry. In an interview with Thomas C. Thottathil, Editor, Indian Pharma Post, Anish Bafna, CEO and MD, Healthium Medtech outlines his plans
In this role, Romanelli will have P&L responsibility for Merck’s US $22 billion international human health business and lead a team of 14,000 colleagues in more than 75 markets outside of the U.S
To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
New product line to address the challenge of restrictions on use of plastic straws
Subscribe To Our Newsletter & Stay Updated
